2016-06-25
The future of stem cells: translational medicine, regenerative medicine and precision medicine
With the progress of medicine and biological sciences, translational medicine focusing on industrialization, regenerative medicine focusing on human body repair, and precision medicine focusing on changing treatment methods are becoming three major emerging fields and important components of the medical community.
2016-04-16
China's biopharmaceutical industry drives social development
The world's richest man, Bill Gates, once predicted that the next richest man in the world who will surpass him will definitely come from the field of genetics.
2016-04-15
What we learned from the collaboration between Abbott, Roche and Nine Power
Mergers, acquisitions and splits in the IVD field have been in full swing, and the same is true for the biochemical diagnostic market in the sub-sector. Recently, the domestic biochemical reagent manufacturer Jiuqiang Biotechnology exported technology to Abbott Diagnostics, a world-leading IVD company. This rare cooperation case has attracted the attention of many industry insiders and has also caused some discussion. In the future, as the competition in China's biochemical market intensifies, especially the competition for the mid- and low-end markets, I believe that such cooperation will increase.
Market overview of stem cell therapy
As a new method that may completely cure cancer, cell therapy has been sought after by various capitals. Large foreign pharmaceutical companies have consolidated their dominant position in the industry through investment, mergers and acquisitions, and strong alliances. Domestic listed companies have also entered the cell therapy market through investment and mergers and acquisitions to get a share of the pie. Representative companies include Yaoji Poker, Xinri Hengli, Beilu Pharmaceutical, Xiangxue Pharmaceutical, etc. This article sorts out the market overview of the stem cell therapy sector in the field of cell therapy.
12
2016/04
Recently, Forbes published an analysis article that looked forward to the technological trends in the medical field in the next five years. Although this prediction is a bit unreasonably optimistic, these five technologies do have the potential to subvert the healthcare industry.
12
2016/04
Four innovative strategies for biotechnology companies to grow
In the June 2015 issue of Harvard Business Review, Dr. Gary P. Pisano, Professor of Business Administration at Harvard Business School, made a convincing case for why companies need innovation strategies and why the absence of innovative initiatives can lead to failure. Furthermore, if a company is to remain competitive, its innovation strategy must continue to evolve.
14
2015/12